Affinity chromatography, when integrated with modern chemical biology, proteomics, and mass spectrometry, provides an effective solution to target identification, mechanism-of-action (MoA) elucidation, and pathway analysis by enabling direct, unbiased capture of interacting proteins from complex biological systems. As a company dedicated to bioactive natural products target identification, we have developed a robust and scalable affinity chromatography–based technology as part of our probe-based approaches, supporting pharmaceutical, biotechnology, and academic research worldwide.
Introduction to Affinity Chromatography
Affinity chromatography is a powerful and highly selective biochemical technique that exploits specific interactions between biomolecules to isolate, enrich, and identify target proteins. In classical formats, a ligand is immobilized onto a solid support (such as agarose or magnetic beads), and a biological sample containing potential binding partners is passed through the matrix. Target proteins bind specifically, while non-interacting components are washed away. Bound proteins are then eluted and analyzed. For target identification studies, the ligand is typically a bioactive compound or its functionalized derivative, designed to retain biological activity while enabling immobilization or enrichment. When applied to natural product research, affinity chromatography offers several unique advantages:
- Direct identification of molecular targets without prior assumptions
- Compatibility with native protein complexes
- Applicability to cell lysates, tissue extracts, or subcellular fractions
- Integration with quantitative proteomics and bioinformatics
By combining affinity chromatography with advanced analytical techniques, researchers can move beyond phenotypic observations toward mechanistic understanding.
Fig. 1. Principle of affinity chromatography [1].
Our Affinity Chromatography-based Technology Platform
Our company has refined this classical technique into a high-throughput, high-sensitivity target identification platform. While traditional affinity chromatography can be plagued by non-specific binding and low recovery of membrane proteins, our platform utilizes proprietary chemical proteomics tools to overcome these hurdles. We specialize in the design and synthesis of functionalized probes derived from your lead compounds. By strategically attaching a linker and a "tag" (such as biotin or a bead-coupling moiety) to the natural product without disrupting its biological activity, we enable the capturing of target proteins in their native physiological state.
Key Methodological Components of Our Platform
- Custom Probe Design: Expert medicinal chemists ensure the pharmacophore remains intact.
- Advanced Matrix Selection: We utilize low-background agarose, magnetic beads, or silica-based resins tailored to the specific protein class.
- Competitive Elution Strategies: To distinguish true targets from "background" proteins, we employ rigorous displacement assays using the free, unmodified natural product.
- Seamless Integration with Proteomics: Captured proteins are identified and quantified using state-of-the-art LC–MS/MS workflows, supported by robust data analysis pipelines.
Typical Workflow Includes:
Step 1
Biological Activity Validation
The biological activity of the natural product is confirmed using relevant phenotypic or biochemical assays to ensure target relevance.
Step 2
Probe Design and Synthesis
Based on structure–activity relationship (SAR) analysis, we design affinity probes that maintain bioactivity. Control probes (inactive analogs or competition assays with free compound) are included to ensure specificity.
Step 3
Affinity Enrichment
The probe is immobilized and incubated with cell or tissue lysates. After stringent washing, specifically bound proteins are enriched.
Step 4
Elution & Digestion
Bound proteins are eluted—often using a competitive "free drug" wash to ensure specificity—and then digested into peptides using trypsin.
Step 5
LC-MS/MS Analysis
We utilize state-of-the-art liquid chromatography-tandem mass spectrometry to identify and quantify the enriched proteins.
Step 6
Bioinformatics & Validation
Our team filters the MS data to identify high-confidence targets, which are then validated through Western blotting or surface plasmon resonance (SPR).
Key Advantages Include:
- Unbiased and Hypothesis-Free: Suitable for complex natural products with unknown mechanisms.
- High Specificity and Sensitivity: Optimized probe design and enrichment conditions minimize false positives.
- Broad Applicability: Compatible with small molecules, secondary metabolites, and complex natural extracts.
- Integrated Expertise:Combines chemistry, biology, and proteomics within a single platform.
Affinity chromatography–based target identification has become an indispensable approach in modern drug discovery, particularly for elucidating the molecular mechanisms of bioactive natural products. Our affinity chromatography–based technology platform integrates rational probe design, optimized enrichment strategies, and advanced proteomics to deliver reliable and actionable target identification results.
Online Inquiry
Reference
- Jiang X., et al. Recent advances in identifying protein targets of bioactive natural products[J]. Heliyon, 2024, 10(13).